| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-08 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.32 | 9e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.31 | 2e-07 |